WO1999002142A3 - Nouvelle composition - Google Patents
Nouvelle composition Download PDFInfo
- Publication number
- WO1999002142A3 WO1999002142A3 PCT/EP1998/004971 EP9804971W WO9902142A3 WO 1999002142 A3 WO1999002142 A3 WO 1999002142A3 EP 9804971 W EP9804971 W EP 9804971W WO 9902142 A3 WO9902142 A3 WO 9902142A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- ssri
- blocker
- beta
- novel composition
- release form
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
- A61K9/2086—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
- A61K9/209—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat containing drug in at least two layers or in the core and in at least one outer layer
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/32—Alcohol-abuse
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5084—Mixtures of one or more drugs in different galenical forms, at least one of which being granules, microcapsules or (coated) microparticles according to A61K9/16 or A61K9/50, e.g. for obtaining a specific release pattern or for combining different drugs
Landscapes
- Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Psychiatry (AREA)
- Pain & Pain Management (AREA)
- Addiction (AREA)
- Epidemiology (AREA)
- Obesity (AREA)
- Hematology (AREA)
- Diabetes (AREA)
- Child & Adolescent Psychology (AREA)
- Hospice & Palliative Care (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
Priority Applications (13)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CA002295822A CA2295822A1 (fr) | 1997-07-11 | 1998-07-07 | Nouvelle composition |
SK7-2000A SK72000A3 (en) | 1997-07-11 | 1998-07-07 | Novel composition comprising an ssri and a beta-blocker |
JP50818599A JP2002508003A (ja) | 1997-07-11 | 1998-07-07 | 新規な組成物 |
IL13386998A IL133869A0 (en) | 1997-07-11 | 1998-07-07 | Novel composition novel formulations comprising an ssri in combination with a beta blocker |
KR1020007000202A KR20010021644A (ko) | 1997-07-11 | 1998-07-07 | 신규한 조성물 |
APAP/P/1999/001728A AP2000001728A0 (en) | 1997-07-11 | 1998-07-07 | Novel composition. |
PL98338017A PL338017A1 (en) | 1997-07-11 | 1998-07-07 | Novel composition |
AU93401/98A AU9340198A (en) | 1997-07-11 | 1998-07-07 | Novel composition |
EA200000112A EA200000112A1 (ru) | 1997-07-11 | 1998-07-07 | Новая композиция |
BR9810996-0A BR9810996A (pt) | 1997-07-11 | 1998-07-07 | Composição farmacêutica |
EP98946294A EP0996466A2 (fr) | 1997-07-11 | 1998-07-07 | Nouvelle composition |
NO20000107A NO20000107L (no) | 1997-07-11 | 2000-01-10 | Ny blanding |
BG104119A BG104119A (en) | 1997-07-11 | 2000-02-01 | A new composition |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB9714675.7 | 1997-07-11 | ||
GBGB9714675.7A GB9714675D0 (en) | 1997-07-11 | 1997-07-11 | Novel composition |
Publications (2)
Publication Number | Publication Date |
---|---|
WO1999002142A2 WO1999002142A2 (fr) | 1999-01-21 |
WO1999002142A3 true WO1999002142A3 (fr) | 1999-04-15 |
Family
ID=10815744
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/EP1998/004971 WO1999002142A2 (fr) | 1997-07-11 | 1998-07-07 | Nouvelle composition |
Country Status (26)
Country | Link |
---|---|
EP (1) | EP0996466A2 (fr) |
JP (1) | JP2002508003A (fr) |
KR (1) | KR20010021644A (fr) |
CN (1) | CN1262627A (fr) |
AP (1) | AP2000001728A0 (fr) |
AR (1) | AR016128A1 (fr) |
AU (1) | AU9340198A (fr) |
BG (1) | BG104119A (fr) |
BR (1) | BR9810996A (fr) |
CA (1) | CA2295822A1 (fr) |
CO (1) | CO4950552A1 (fr) |
DZ (1) | DZ2556A1 (fr) |
EA (1) | EA200000112A1 (fr) |
GB (1) | GB9714675D0 (fr) |
HU (1) | HUP0003074A3 (fr) |
ID (1) | ID24191A (fr) |
IL (1) | IL133869A0 (fr) |
MA (1) | MA24604A1 (fr) |
NO (1) | NO20000107L (fr) |
OA (1) | OA11276A (fr) |
PE (1) | PE99699A1 (fr) |
PL (1) | PL338017A1 (fr) |
SK (1) | SK72000A3 (fr) |
TR (1) | TR200000074T2 (fr) |
WO (1) | WO1999002142A2 (fr) |
ZA (1) | ZA986138B (fr) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8951555B1 (en) | 2000-10-30 | 2015-02-10 | Purdue Pharma L.P. | Controlled release hydrocodone formulations |
US8975273B2 (en) | 1999-10-29 | 2015-03-10 | Purdue Pharma L.P. | Controlled release hydrocodone formulations |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
PT1121111E (pt) | 1998-10-15 | 2010-05-17 | Imp Innovations Ltd | Compostos para o tratamento de perda de peso |
ID29852A (id) | 1998-11-02 | 2001-10-18 | Elan Corp Plc Cs | Komposisi pelepasan modifikasi multi partikulasi |
US10179130B2 (en) | 1999-10-29 | 2019-01-15 | Purdue Pharma L.P. | Controlled release hydrocodone formulations |
GB0004003D0 (en) * | 2000-02-22 | 2000-04-12 | Knoll Ag | Therapeutic agents |
AU2005283829A1 (en) * | 2004-09-17 | 2006-03-23 | Neurocure Ltd | Pindolol for the treating premenstrual syndrome and premenstrual dysphoric disorder |
CN100469356C (zh) * | 2006-09-08 | 2009-03-18 | 山东益康药业有限公司 | 复方阿替洛尔缓释片及其制备方法 |
Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
BE857122A (fr) * | 1976-07-27 | 1978-01-25 | Sandoz Sa | Nouvelle composition pharmaceutique permettant une liberation controlee de la substance active |
EP0687472A2 (fr) * | 1994-06-16 | 1995-12-20 | Eli Lilly And Company | Potentialisation d'un médicament par un antagoniste du récepteur sérotonine 1A |
EP0714663A2 (fr) * | 1994-11-28 | 1996-06-05 | Eli Lilly And Company | Potentialisation d'un médicament par un antagoniste du récepteur sérotonine 1A |
WO1997006792A1 (fr) * | 1995-08-16 | 1997-02-27 | Eli Lilly And Company | Potentialisation de la production de serotonine |
EP0792649A1 (fr) * | 1996-02-29 | 1997-09-03 | Eli Lilly And Company | Traitement de l'insomnie |
-
1997
- 1997-07-11 GB GBGB9714675.7A patent/GB9714675D0/en active Pending
-
1998
- 1998-07-07 AP APAP/P/1999/001728A patent/AP2000001728A0/en unknown
- 1998-07-07 HU HU0003074A patent/HUP0003074A3/hu unknown
- 1998-07-07 ID IDW20000035A patent/ID24191A/id unknown
- 1998-07-07 PL PL98338017A patent/PL338017A1/xx unknown
- 1998-07-07 TR TR2000/00074T patent/TR200000074T2/xx unknown
- 1998-07-07 CN CN98806975A patent/CN1262627A/zh active Pending
- 1998-07-07 BR BR9810996-0A patent/BR9810996A/pt not_active Application Discontinuation
- 1998-07-07 JP JP50818599A patent/JP2002508003A/ja active Pending
- 1998-07-07 EA EA200000112A patent/EA200000112A1/ru unknown
- 1998-07-07 IL IL13386998A patent/IL133869A0/xx unknown
- 1998-07-07 CA CA002295822A patent/CA2295822A1/fr not_active Abandoned
- 1998-07-07 EP EP98946294A patent/EP0996466A2/fr not_active Withdrawn
- 1998-07-07 AU AU93401/98A patent/AU9340198A/en not_active Abandoned
- 1998-07-07 SK SK7-2000A patent/SK72000A3/sk unknown
- 1998-07-07 WO PCT/EP1998/004971 patent/WO1999002142A2/fr not_active Application Discontinuation
- 1998-07-07 KR KR1020007000202A patent/KR20010021644A/ko not_active Application Discontinuation
- 1998-07-08 DZ DZ980166A patent/DZ2556A1/fr active
- 1998-07-10 CO CO98039260A patent/CO4950552A1/es unknown
- 1998-07-10 ZA ZA9806138A patent/ZA986138B/xx unknown
- 1998-07-10 AR ARP980103371A patent/AR016128A1/es unknown
- 1998-07-10 MA MA25165A patent/MA24604A1/fr unknown
- 1998-07-10 PE PE1998000612A patent/PE99699A1/es not_active Application Discontinuation
-
2000
- 2000-01-10 NO NO20000107A patent/NO20000107L/no not_active Application Discontinuation
- 2000-01-11 OA OA1200000006A patent/OA11276A/en unknown
- 2000-02-01 BG BG104119A patent/BG104119A/xx unknown
Patent Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
BE857122A (fr) * | 1976-07-27 | 1978-01-25 | Sandoz Sa | Nouvelle composition pharmaceutique permettant une liberation controlee de la substance active |
EP0687472A2 (fr) * | 1994-06-16 | 1995-12-20 | Eli Lilly And Company | Potentialisation d'un médicament par un antagoniste du récepteur sérotonine 1A |
EP0714663A2 (fr) * | 1994-11-28 | 1996-06-05 | Eli Lilly And Company | Potentialisation d'un médicament par un antagoniste du récepteur sérotonine 1A |
WO1997006792A1 (fr) * | 1995-08-16 | 1997-02-27 | Eli Lilly And Company | Potentialisation de la production de serotonine |
EP0792649A1 (fr) * | 1996-02-29 | 1997-09-03 | Eli Lilly And Company | Traitement de l'insomnie |
Non-Patent Citations (2)
Title |
---|
"PINDOLOL INDUCES A RAPID IMPROVEMENT OF DEPRESSED PATIENTS TREATED WITH SEROTONIN REUPTAKE INHIBITORS", ARCHIVES OF GENERAL PSYCHIATRY, vol. 51, no. 3, March 1994 (1994-03-01), pages 248 - 251, XP000605678 * |
HJORTH S ET AL: "FURTHER EVIDENCE FOR THE INPORTANCE OF 5-HT1A AUTORECEPTORS IN THE ACTION OF SELECTIVE SEROTONIN REUPTAKE INHIBITORS", EUROPEAN JOURNAL OF PHARMACOLOGY, vol. 260, 1994, pages 251 - 255, XP000605645 * |
Cited By (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US9320717B2 (en) | 1999-10-29 | 2016-04-26 | Purdue Pharma L.P. | Controlled release hydrocodone formulations |
US8975273B2 (en) | 1999-10-29 | 2015-03-10 | Purdue Pharma L.P. | Controlled release hydrocodone formulations |
US9278074B2 (en) | 1999-10-29 | 2016-03-08 | Purdue Pharma L.P. | Controlled release hydrocodone formulations |
US9056107B1 (en) | 1999-10-29 | 2015-06-16 | Purdue Pharma L.P. | Controlled release hydrocodone formulations |
US9289391B2 (en) | 2000-10-30 | 2016-03-22 | Purdue Pharma L.P. | Controlled release hydrocodone formulations |
US9205056B2 (en) | 2000-10-30 | 2015-12-08 | Purdue Pharma L.P. | Controlled release hydrocodone formulations |
US9198863B2 (en) | 2000-10-30 | 2015-12-01 | Purdue Pharma L.P. | Controlled release hydrocodone formulations |
US9023401B1 (en) | 2000-10-30 | 2015-05-05 | Purdue Pharma L.P. | Controlled release hydrocodone formulations |
US9205055B2 (en) | 2000-10-30 | 2015-12-08 | Purdue Pharma L.P. | Controlled release hydrocodone formulations |
US8951555B1 (en) | 2000-10-30 | 2015-02-10 | Purdue Pharma L.P. | Controlled release hydrocodone formulations |
US9504681B2 (en) | 2000-10-30 | 2016-11-29 | Purdue Pharma L.P. | Controlled release hydrocodone formulations |
US9517236B2 (en) | 2000-10-30 | 2016-12-13 | Purdue Pharma L.P. | Controlled release hydrocodone formulations |
US9526724B2 (en) | 2000-10-30 | 2016-12-27 | Purdue Pharma L.P. | Controlled release hydrocodone formulations |
US9572804B2 (en) | 2000-10-30 | 2017-02-21 | Purdue Pharma L.P. | Controlled release hydrocodone formulations |
US9572805B2 (en) | 2000-10-30 | 2017-02-21 | Purdue Pharma L.P. | Controlled release hydrocodone formulations |
Also Published As
Publication number | Publication date |
---|---|
CO4950552A1 (es) | 2000-09-01 |
NO20000107D0 (no) | 2000-01-10 |
OA11276A (en) | 2003-07-31 |
CA2295822A1 (fr) | 1999-01-21 |
EA200000112A1 (ru) | 2000-10-30 |
GB9714675D0 (en) | 1997-09-17 |
EP0996466A2 (fr) | 2000-05-03 |
AU9340198A (en) | 1999-02-08 |
HUP0003074A2 (hu) | 2001-01-29 |
BG104119A (en) | 2000-12-29 |
IL133869A0 (en) | 2001-04-30 |
MA24604A1 (fr) | 1999-04-01 |
ZA986138B (en) | 2000-01-10 |
JP2002508003A (ja) | 2002-03-12 |
ID24191A (id) | 2000-07-13 |
NO20000107L (no) | 2000-01-10 |
AR016128A1 (es) | 2001-06-20 |
AP2000001728A0 (en) | 2000-03-31 |
HUP0003074A3 (en) | 2001-12-28 |
SK72000A3 (en) | 2000-12-11 |
TR200000074T2 (tr) | 2000-05-22 |
PE99699A1 (es) | 1999-12-21 |
WO1999002142A2 (fr) | 1999-01-21 |
CN1262627A (zh) | 2000-08-09 |
DZ2556A1 (fr) | 2003-02-15 |
KR20010021644A (ko) | 2001-03-15 |
BR9810996A (pt) | 2000-08-08 |
PL338017A1 (en) | 2000-09-25 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU6873398A (en) | Table construction | |
AU6311698A (en) | Immunopotentiators | |
AU2630697A (en) | Connection base | |
AU4073997A (en) | 1,4-heterocyclic metallprotease inhibitors | |
HK1027983A1 (en) | Sustained-release compositions and method for preparing same. | |
AU6535098A (en) | Zcytor7 cytokine receptor | |
AU6244098A (en) | Distributed game | |
AU6740298A (en) | Pharmaceutical composition | |
AU5387898A (en) | Pharmaceutical agents | |
AU6148698A (en) | Tetralone derivatives as antiarrhythmic agents | |
AU8350498A (en) | Disintegration apparatus | |
AUPP038697A0 (en) | Improved stomach-action molluscicides | |
WO1999002142A3 (fr) | Nouvelle composition | |
AU9343098A (en) | Pharmaceutical composition | |
AU5882298A (en) | New analgesic composition | |
AU4071897A (en) | Nmda (n-methyl-d-aspartate) antagonists | |
AU2704799A (en) | Improved gaming table tracking system and method | |
AU4068197A (en) | Brazing and preparing articles for brazing | |
AU8069898A (en) | Computerized craft for creating jewelry and other art curios | |
AU7675198A (en) | Sucralfate-containing composition and process for the preparation thereof | |
AU9335998A (en) | Bagatelle table | |
AU1906599A (en) | Pancreatic-derived factors, and uses related thereto | |
ZA9810472B (en) | An antimalarial composition | |
AU4630896A (en) | Football support | |
AU1998997A (en) | Sorting table |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
WWE | Wipo information: entry into national phase |
Ref document number: 133869 Country of ref document: IL Ref document number: 98806975.X Country of ref document: CN |
|
AK | Designated states |
Kind code of ref document: A2 Designated state(s): AL AM AT AU AZ BA BB BG BR BY CA CH CN CU CZ DE DK EE ES FI GB GE GH GM GW HR HU ID IL IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT UA UG US UZ VN YU ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A2 Designated state(s): GH GM KE LS MW SD SZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN ML MR NE SN TD TG |
|
AK | Designated states |
Kind code of ref document: A3 Designated state(s): AL AM AT AU AZ BA BB BG BR BY CA CH CN CU CZ DE DK EE ES FI GB GE GH GM GW HR HU ID IL IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT UA UG US UZ VN YU ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A3 Designated state(s): GH GM KE LS MW SD SZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN ML MR NE SN TD TG |
|
DFPE | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101) | ||
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
WWE | Wipo information: entry into national phase |
Ref document number: 1998946294 Country of ref document: EP |
|
WWE | Wipo information: entry into national phase |
Ref document number: 501257 Country of ref document: NZ |
|
WWE | Wipo information: entry into national phase |
Ref document number: 93401/98 Country of ref document: AU |
|
WWE | Wipo information: entry into national phase |
Ref document number: 72000 Country of ref document: SK |
|
WWE | Wipo information: entry into national phase |
Ref document number: 09462391 Country of ref document: US |
|
ENP | Entry into the national phase |
Ref document number: 2295822 Country of ref document: CA Ref document number: 2295822 Country of ref document: CA Kind code of ref document: A |
|
WWE | Wipo information: entry into national phase |
Ref document number: PA/a/2000/000416 Country of ref document: MX Ref document number: PV2000-81 Country of ref document: CZ Ref document number: 1020007000202 Country of ref document: KR |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2000/00074 Country of ref document: TR |
|
WWE | Wipo information: entry into national phase |
Ref document number: 200000112 Country of ref document: EA |
|
WWP | Wipo information: published in national office |
Ref document number: 1998946294 Country of ref document: EP |
|
REG | Reference to national code |
Ref country code: DE Ref legal event code: 8642 |
|
WWP | Wipo information: published in national office |
Ref document number: PV2000-81 Country of ref document: CZ |
|
WWP | Wipo information: published in national office |
Ref document number: 1020007000202 Country of ref document: KR |
|
WWW | Wipo information: withdrawn in national office |
Ref document number: 1998946294 Country of ref document: EP |
|
WWW | Wipo information: withdrawn in national office |
Ref document number: 1020007000202 Country of ref document: KR |
|
WWR | Wipo information: refused in national office |
Ref document number: PV2000-81 Country of ref document: CZ |